Evidence map›Paper›PMID 31729636›Full record

SynthesisJournal of neuro-oncology2019

Radiation chronotherapy-clinical impact of treatment time-of-day: a systematic review.

Dorela D Shuboni-Mulligan, Ghislain Breton, DeeDee Smart, Mark Gilbert, Terri S Armstrong

Open access · greenAbstract readSystematic Review
In one paragraph

Synthesis in Journal of neuro-oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 44 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Dorela D Shuboni-MulliganNeuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Dorela.Shuboni-Mulligan@nih.gov.ORCID http://orcid.org/0000-0001-7575-8666
Ghislain BretonDepartment of Integrative Biology and Pharmacology, McGovern Medical School, University of Texas Health Science Center at Houston, Houston, TX, USA.ORCID http://orcid.org/0000-0001-6400-3858
DeeDee SmartRadiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0003-3471-0871
Mark GilbertNeuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0003-2556-9722
Terri S ArmstrongNeuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.ORCID http://orcid.org/0000-0002-2414-0492
National Institutes of Health · USThe University of Texas Health Science Center at Houston · US

Funding

Natural History and Specimen Banking for Patients with CNS TumorsZIABC011768 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI ARMSTRONG, TERRI S. · 2017 to 2024
$6.7M
Bioinformatics: Characterizing Brain Tumor DateZIABC011784 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI GILBERT, MARK · 2017 to 2024
$4.9M
Neuropsychological outcome measures in patients receiving whole brain radiationZIABC011333 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI SMART, DEEDEE · 2010 to 2025
$4.6M
Outcomes and Risk of Rare TumorsZIABC011837 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI ARMSTRONG, TERRI S. · 2018 to 2024
$2.7M
Intramural NIH HHS ZIA BC011333Intramural NIH HHS ZIA BC011768Intramural NIH HHS ZIA BC011784Intramural NIH HHS ZIA BC011837NCI NIH HHS Intramural Research Program
6 · The paper itself

Abstract

purposeMany brain tumor patients suffer from radiation-induced toxicities. Chronotherapy is a treatment modality that utilizes circadian rhythms to optimize the effect on tumor while minimizing negative outcomes on healthy tissue. This review aims to systematically examine the literature on the application of a radiation chronotherapeutic for all cancers and determine the possible advantages of incorporating a circadian-based fixed time-of-day for radiotherapy into CNS cancers.

methodsA systematic review of the literature was conducted in two electronic databases from inception to February 1, 2019. Primary research manuscripts were screened for those related to adult human subjects exposed to ionizing radiation using the chronotherapy technique.

resultsNine manuscripts were included in the review from 79 eligible articles. Three were prospective randomized trails and 6 were retrospective reviews. This survey revealed that overall survival and tumor control do not have consistent effects with only 60% and 55.5% of paper which included the variables having some significance, respectively. Treatment symptoms were the primary endpoint for both the prospective trials and were examined in 3 of the retrospective reviews; effects were observed in sensitive tissue for all 5 studies including mucosal linings and skin basal layer.

conclusionsExisting literature suggests that the application of radiation chronotherapy may reduce negative symptom outcome within highly proliferative tissues. Further examination of radiation chronotherapy in well-designed prospective trials and studies in brain tumor patients are merited.

Indexed as

ChronotherapyHumansNeoplasmsRadiotherapyChronotherapyOutcomesRadiationRadiotherapySymptom burden

Identifiers

PMID31729636
PMCPMC8130840
OpenAlexW2983499497

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.